These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 24992699)
1. Preparation and characterization of spray-dried inhalable powders containing nanoaggregates for pulmonary delivery of anti-tubercular drugs. Kaur R; Garg T; Das Gupta U; Gupta P; Rath G; Goyal AK Artif Cells Nanomed Biotechnol; 2016; 44(1):182-7. PubMed ID: 24992699 [TBL] [Abstract][Full Text] [Related]
2. Development and characterization of spray-dried porous nanoaggregates for pulmonary delivery of anti-tubercular drugs. Kaur R; Garg T; Malik B; Gupta UD; Gupta P; Rath G; Goyal AK Drug Deliv; 2016; 23(3):882-7. PubMed ID: 24870203 [TBL] [Abstract][Full Text] [Related]
3. Preparation and characterization of spray dried inhalable powders containing chitosan nanoparticles for pulmonary delivery of isoniazid. Pourshahab PS; Gilani K; Moazeni E; Eslahi H; Fazeli MR; Jamalifar H J Microencapsul; 2011; 28(7):605-13. PubMed ID: 21793647 [TBL] [Abstract][Full Text] [Related]
4. Spray-dried particles as pulmonary delivery system of anti-tubercular drugs: design, optimization, in vitro and in vivo evaluation. Garg T; Goyal AK; Rath G; Murthy RS Pharm Dev Technol; 2016 Dec; 21(8):951-960. PubMed ID: 26334961 [TBL] [Abstract][Full Text] [Related]
5. Rifampicin loaded chitosan nanoparticle dry powder presents an improved therapeutic approach for alveolar tuberculosis. Rawal T; Parmar R; Tyagi RK; Butani S Colloids Surf B Biointerfaces; 2017 Jun; 154():321-330. PubMed ID: 28363192 [TBL] [Abstract][Full Text] [Related]
6. Inhalable chitosan nanoparticles as antitubercular drug carriers for an effective treatment of tuberculosis. Garg T; Rath G; Goyal AK Artif Cells Nanomed Biotechnol; 2016 May; 44(3):997-1001. PubMed ID: 25682840 [TBL] [Abstract][Full Text] [Related]
7. Preparation and in vivo absorption evaluation of spray dried powders containing salmon calcitonin loaded chitosan nanoparticles for pulmonary delivery. Sinsuebpol C; Chatchawalsaisin J; Kulvanich P Drug Des Devel Ther; 2013; 7():861-73. PubMed ID: 24039397 [TBL] [Abstract][Full Text] [Related]
8. Phospholipid-based pyrazinamide spray-dried inhalable powders for treating tuberculosis. Eedara BB; Tucker IG; Das SC Int J Pharm; 2016 Jun; 506(1-2):174-83. PubMed ID: 27091294 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of highly branched cyclic dextrin in inhalable particles of combined antibiotics for the pulmonary delivery of anti-tuberculosis drugs. Kadota K; Senda A; Tagishi H; Ayorinde JO; Tozuka Y Int J Pharm; 2017 Jan; 517(1-2):8-18. PubMed ID: 27913241 [TBL] [Abstract][Full Text] [Related]
11. [Design of Spray-dried Porous Particles for Sugar-based Dry Powder Inhaler Formulation]. Kadota K Yakugaku Zasshi; 2018; 138(9):1163-1167. PubMed ID: 30175760 [TBL] [Abstract][Full Text] [Related]
12. Preparation and characterisation of novel spray-dried nano-structured para-aminosalicylic acid particulates for pulmonary delivery: impact of ammonium carbonate on morphology, chemical composition and solid state. Gad S; Tajber L; Corrigan OI; Healy AM J Pharm Pharmacol; 2012 Sep; 64(9):1264-74. PubMed ID: 22881439 [TBL] [Abstract][Full Text] [Related]
13. Targeted intracellular delivery of antituberculosis drugs to Mycobacterium tuberculosis-infected macrophages via functionalized mesoporous silica nanoparticles. Clemens DL; Lee BY; Xue M; Thomas CR; Meng H; Ferris D; Nel AE; Zink JI; Horwitz MA Antimicrob Agents Chemother; 2012 May; 56(5):2535-45. PubMed ID: 22354311 [TBL] [Abstract][Full Text] [Related]
14. Optimization and dissolution performance of spray-dried naproxen nano-crystals. Kumar S; Shen J; Zolnik B; Sadrieh N; Burgess DJ Int J Pharm; 2015; 486(1-2):159-66. PubMed ID: 25814034 [TBL] [Abstract][Full Text] [Related]
15. Spray-dried powders enhance vaginal siRNA delivery by potentially modulating the mucus molecular sieve structure. Wu N; Zhang X; Li F; Zhang T; Gan Y; Li J Int J Nanomedicine; 2015; 10():5383-96. PubMed ID: 26347257 [TBL] [Abstract][Full Text] [Related]
16. In vivo/in vitro pharmacokinetic and pharmacodynamic study of spray-dried poly-(dl-lactic-co-glycolic) acid nanoparticles encapsulating rifampicin and isoniazid. Booysen LL; Kalombo L; Brooks E; Hansen R; Gilliland J; Gruppo V; Lungenhofer P; Semete-Makokotlela B; Swai HS; Kotze AF; Lenaerts A; du Plessis LH Int J Pharm; 2013 Feb; 444(1-2):10-7. PubMed ID: 23357255 [TBL] [Abstract][Full Text] [Related]
17. Docetaxel-Loaded Cholesterol-PEG Co-Modified Poly (n-Butyl) Cyanoacrylate Nanoparticles for Antitumor Drug Pulmonary Delivery: Preparation, Characterization, and in vivo Evaluation. Hu X; Yang F; Liao Y; Li L; Zhao G; Zhang L Int J Nanomedicine; 2020; 15():5361-5376. PubMed ID: 32801694 [TBL] [Abstract][Full Text] [Related]
18. Nanocrystals embedded in chitosan-based respirable swellable microparticles as dry powder for sustained pulmonary drug delivery. Ni R; Zhao J; Liu Q; Liang Z; Muenster U; Mao S Eur J Pharm Sci; 2017 Mar; 99():137-146. PubMed ID: 27988327 [TBL] [Abstract][Full Text] [Related]
19. Development of Sustained Release Oseltamivir Phosphate Dry Powder Inhaler: Sahastrabudhe H; Kenjale P; Pokharkar V Curr Drug Deliv; 2020; 17(8):703-710. PubMed ID: 32472998 [TBL] [Abstract][Full Text] [Related]
20. Spray-dried fucoidan microparticles for pulmonary delivery of antitubercular drugs. Cunha L; Rosa da Costa AM; Lourenço JP; Buttini F; Grenha A J Microencapsul; 2018 Jun; 35(4):392-405. PubMed ID: 30112917 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]